Sonya McKinney
Nurse Practitioner · Mount Vernon, ILNPI 1407221484
Payments from drug & device makers
Across 456 payments — averaging $14.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$2K
- AstraZeneca$501
- GSK$321
- Lilly USA, LLC$255
- Pfizer$211
- plus $1K from 29 others
What the payments were for
- Food & beverage$6,394100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,394 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 128 | $182,834 |
| EliquisApixaban | 117 | $99,853 |
| TrulicityDulaglutide | 47 | $54,168 |
| JanuviaSitagliptin Phosphate | 48 | $49,917 |
| JardianceEmpagliflozin | 36 | $41,978 |
| RybelsusSemaglutide | 21 | $39,889 |
| MounjaroTirzepatide | 30 | $37,961 |
| FarxigaDapagliflozin Propanediol | 33 | $35,937 |
| VraylarCariprazine Hcl | 20 | $31,357 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $28,268 |
| TrintellixVortioxetine Hydrobromide | 31 | $19,293 |
| Breo ElliptaFluticasone/Vilanterol | 39 | $18,331 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $14,652 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $12,133 |
| LinzessLinaclotide | 12 | $11,469 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,741 | $222,723149 claims |
| PfizerEliquis | $211 | $99,853117 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $255 | $92,13077 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Anoro Ellipta | $321 | $63,911116 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $501 | $48,07045 claims |
| AbbVieVraylar, Linzess, Synthroid | $1,973 | $45,02063 claims |
| Boehringer IngelheimJardiance | $45 | $41,97836 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $32 | $19,29331 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $37 | $9,80212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Mount Vernon
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.